Literature DB >> 6282548

Pancreatic enzyme replacement: the effect of antacids or cimetidine.

D Y Graham.   

Abstract

The effect of the addition of sodium bicarbonate, aluminum hydroxide, magnesium hydroxide, calcium carbonate, or cimetidine to supplemental pancreatic enzyme therapy was investigated in patients with severe exocrine pancreatic insufficiency. Steatorrhea was reduced with the administration of three enzyme tablets with meals (73 vs 29 g/24 hr). The coadministration of enzyme tablets with either sodium bicarbonate (16.6 g/24 hr, P = 0.08), or aluminum hydroxide (18.4 g/24 hr, P = 0.029) yielded a greater reduction in steatorrhea than enzymes alone (29 g/24 hr). Neither magnesium-aluminum hydroxide (36.3 g/24 hr, P = 0.22), nor calcium carbonate (39.0 g/24 hr, P = 0.029), improved efficacy of enzyme therapy and, in fact, tended to enhance steatorrhea. With the administration of cimetidine there was no significant effect on steatorrhea compared to enzymes alone (32.1 vs 29 g/24 hr, P greater than 0.3). Intraduodenal lipase activity following test meals was found to be a poor predictor of the effectiveness of antacid therapy in improving the efficacy of supplemental enzymes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282548     DOI: 10.1007/bf01296725

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Effect of sodium bicarbonate and pancreatin on the absorption of vitamin B12 and fat in pancreatic insufficiency.

Authors:  W VEEGER; J ABELS; N HELLEMANS; H O NIEWEG
Journal:  N Engl J Med       Date:  1962-12-27       Impact factor: 91.245

2.  The influence of ingestion of calcium and other soap-forming substances on fecal fat.

Authors:  E J DRENICK
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

3.  Distribution and fate of pancreatic enzymes in small intestine of the rat.

Authors:  D PELOT; M I GROSSMAN
Journal:  Am J Physiol       Date:  1962-02

4.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

Review 5.  Detergent properties of bile salts: correlation with physiological function.

Authors:  A F Hofmann; D M Small
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

6.  Achlorhydria associated with chronic disease of the exocrine pancreas.

Authors:  I F MacLaren; J M Howard; O Serlin
Journal:  Surgery       Date:  1966-05       Impact factor: 3.982

Review 7.  Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis.

Authors:  A M Weber; C C Roy; L Chartrand; G Lepage; O L Dufour; C L Morin; R Lasalle
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

8.  Gastric secretion of acid in patients with pancreatic disease.

Authors:  J H Saunders; J M Cargill; K G Wormsley
Journal:  Digestion       Date:  1978 Jul-Aug       Impact factor: 3.216

9.  The effect of cimetidine on maldigestion in cystic fibrosis.

Authors:  K L Cox; J N Isenberg; A B Osher; R R Dooley
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

10.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

View more
  21 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Enzyme contents of pancreatic extract preparations. Are they optimal?

Authors:  S Maguire; M C Goodchild
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 3.  Uses and abuses of enzyme therapy in cystic fibrosis.

Authors:  P Durie; D Kalnins; L Ellis
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

Review 4.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

5.  Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations.

Authors:  A M Whitehead
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

6.  Non-invasive assessment of intraluminal lipolysis using a 13CO2 breath test.

Authors:  M S Murphy; E J Eastham; R Nelson; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

7.  Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.

Authors:  S K Dutta; V S Hubbard; M Appler
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

8.  Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.

Authors:  T A Robb; G P Davidson; C Kirubakaran
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

9.  Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy.

Authors:  M J Bruno; E A Rauws; F J Hoek; G N Tytgat
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

10.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.